Next quarter’s earnings estimate for TH is C$0.07 with a range of C$0.06 to C$0.09. The previous quarter’s EPS was C$0.09. TH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.00% of the time in the same period. In the last calendar year TH has Outperformed its overall industry.

TH Sales Forecast

Next quarter’s sales forecast for TH is C$32.69M with a range of C$32.26M to C$33.12M. The previous quarter’s sales results were C$30.95M. TH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 44.44% of the time in the same period. In the last calendar year TH has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Andre Uddin

Research Capital

C$5.48

Buy

163.32%

Upside

Upgraded

10/22/24

THTX upgraded at Research CapitalUddin thinks THTX will post EPS of $0.03 on revenue of $84.0-million in fiscal 2024. He expects those numbers will improve to EPS of $0.07 on a topline of $87.0-million in fiscal 2025.

Justin Walsh

JonesTrading

―

Hold

―

Downgraded

10/10/24

Theratechnologies (THTX) was downgraded to a Hold Rating at JonesTrading

William Maughan

Clear Street

C$11.53→C$7.21

Hold

246.47%

Upside

Reiterated

02/22/24

Theratechnologies price target lowered to $5 from $8 at CanaccordTheratechnologies price target lowered to $5 from $8 at Canaccord

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Theratechnologies

Which Analyst Should I Follow If I Want to Buy TSE:TH and Sell After:

1 Month

xxx

Success Rate

6/14 ratings generated profit

Average Return

-3.39%

upgraded a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 42.86% of your transactions generating a profit, with an average return of -3.39% per trade.

3 Months

xxx

Success Rate

6/14 ratings generated profit

Average Return

-0.97%

upgraded a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -0.97% per trade.

1 Year

Andre UddinResearch Capital

Success Rate

7/14 ratings generated profit

Average Return

+3.60%

upgraded a buy rating 3 months ago

Copying Andre Uddin's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.60% per trade.

2 Years

xxx

Success Rate

4/14 ratings generated profit

Average Return

-24.52%

upgraded a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -24.52% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TH Analyst Recommendation Trends

Rating

Feb 24

May 24

Jul 24

Oct 24

Jan 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TH has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. TH average Analyst price target in the past 3 months is C$3.80.

Each month's total comprises the sum of three months' worth of ratings.

TH Stock Forecast FAQ

What is TSE:TH’s average 12-month price target, according to analysts?

Based on analyst ratings, Theratechnologies Inc’s 12-month average price target is C$3.80.

What is TSE:TH’s upside potential, based on the analysts’ average price target?

Theratechnologies Inc has 82.69% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TSE:TH a Buy, Sell or Hold?

Theratechnologies Inc has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.

What is Theratechnologies Inc’s price target?

The average price target for Theratechnologies Inc is C$3.80. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$5.49 ,the lowest forecast is C$5.49. The average price target represents 82.69% Increase from the current price of C$2.08.

What do analysts say about Theratechnologies Inc?

Theratechnologies Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.

How can I buy shares of TSE:TH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Theratechnologies (TH) Stock Forecast & Price Target

TH Analyst Ratings

TH Stock 12 Month Forecast

TH Financial Forecast

TH Earnings Forecast

TH Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering Theratechnologies

TH Analyst Recommendation Trends

TH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts